|Articles|February 1, 2012

Toshiba's Latest Aquilion CT Receives FDA Clearance

The Aquilion Prime CT was designed for facilities that need to perform a wide variety of advanced clinical exams and produce high-quality clinical images with reduced radiation exposure, the company said.

The latest addition to Toshiba’s Aquilion CT product line has received FDA 510(k) clearance, the company announced.

The Aquilion Prime CT was designed for healthcare facilities that need to perform a wide variety of advanced clinical exams and produce high-quality clinical images with reduced radiation exposure, according to Toshiba America Medical Systems, Inc. The system has double-slice technology and the coneXact reconstruction algorithm, and can generate 160 unique slices per rotation, enhancing MPR and 3-D-rendered images.

The Aquilion Prime features an 80-row, 0.5 mm detector, a 7.5 MHU large-capacity tube, and a 0.35-second scanning. This allows for rapid data acquisition and shorter scan times, and the faster reconstruction aims to improve throughput, the company said. The system has a 78-cm aperture gantry, and a 660-pound patient-weight capacity couch.

The system features the Adaptive Iterative Dose Reduction, the iterative process for reducing noise from the image, and NEMA XR 25 Dose Check software, aimed at increasing user awareness of dose.


Related to this article

Does kV Still Matter in Photon-Counting CT?
Emerging research demonstrates the increasing stability of attenuation on clinically relevant VMIs with photon-counting CT and a redefined role of kV that may have implications for longitudinal quantitative CT.
CT Radiation Dosing: Where Things Stand, Part 2
In the second of a two-part interview, Kalpana Kanal, PhD, and Mahadevappa Mahesh, MS, PhD, FAPPM, FACR, discussed future directions for research on CT radiation dosing, including the potential of indication-specific diagnostic reference levels (DRLs).
CT Radiation Dosing: Where Things Stand, Part 1
In the first of a two-part interview, Kalpana Kanal, PhD, and Mahadevappa Mahesh, MS, PhD, FAPPM, FACR, discussed recently published research showing significant declines in computed tomography (CT) radiation dosing over the past decade.